placeholder image
R. S. Mazze All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis. 
    Endocrine Practice. 2019
  • Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: an analysis using continuous glucose monitoring. 
    Diabetes/Metabolism Research and Reviews. 2017
  • A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes. 
    Diabetes care. 2014
  • Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol). 
    Endocrine Practice. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 
    Diabetes Technology & Therapeutics. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2013
  • International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece. 
    Diabetes Technology & Therapeutics. 2011
  • Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. 
    Endocrine Practice. 2009
  • Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?. 
    Diabetes Technology & Therapeutics. 2009
  • Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorizacao da Assistencia ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia). 
    Diabetic Medicine. 2009
  • Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. 
    Diabetes Technology & Therapeutics. 2008
  • Partners in advancing care and education solutions study: impact on processes and outcomes of diabetes care. 
    Population health management. 2008
  • Physician pay-for-performance. Implementation and research issues. 
    Journal of General Internal Medicine. 2006
  • Making sense of glucose monitoring technologies: from SMBG to CGM. 
    Diabetes Technology & Therapeutics. 2005
  • Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles. 
    Blood Pressure. 2004
  • Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure. 
    Diabetic Medicine. 2003
  • Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. 
    Journal of the American Dietetic Association. 1995
  • Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. 
    Journal of the American Dietetic Association. 1995
  • A joint venture with the commonwealth of independent states. 
    Diabetes care. 1993
  • Practice guidelines for nutrition care by dietetics practitioners for outpatients with non-insulin-dependent diabetes mellitus: methodologies for field-testing and cost-effectiveness analysis. 
    Journal of the American Dietetic Association. 1992
    • Review
  • An overview of continuous glucose monitoring and the ambulatory glucose profile [review]. 
    Minnesota Medicine. 2011
  • Intensified diabetes management: lessons from the diabetes control and complications trial [review]. 
    International Journal of Clinical Pharmacology and Therapeutics. 1995
    • Abstract
  • Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract]. 
    Diabetes. 2015
    • Book
  • China Initiative for Diabetes Excellence (CIDE): clinical status of 2143 individuals from 27 provinces with type 2 diabetes
    2013
    • Contact
    full name
  • R. S. Mazze
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration